{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "BBC",
        "Security_Name": "Virtus LifeSci Biotech Clinical Trials ETF",
        "Listing_Exchange": "P",
        "Market_Category": "",
        "ETF": "Y",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "",
        "CQS_Symbol": "BBC",
        "NASDAQ_Symbol": "BBC",
        "NextShares": "N"
    },
    "history": [],
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 2,
        "previousClose": 24.48,
        "open": 24.59,
        "dayLow": 24.59,
        "dayHigh": 25.07,
        "regularMarketPreviousClose": 24.48,
        "regularMarketOpen": 24.59,
        "regularMarketDayLow": 24.59,
        "regularMarketDayHigh": 25.07,
        "volume": 1590,
        "regularMarketVolume": 1590,
        "averageVolume": 2983,
        "averageVolume10days": 2980,
        "averageDailyVolume10Day": 2980,
        "bid": 23.97,
        "ask": 25.42,
        "bidSize": 1300,
        "askSize": 1000,
        "yield": 0,
        "totalAssets": 17194252,
        "fiftyTwoWeekLow": 17.77,
        "fiftyTwoWeekHigh": 34.806,
        "fiftyDayAverage": 24.8908,
        "twoHundredDayAverage": 24.291365,
        "navPrice": 25.46,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 2,
        "category": "Health",
        "ytdReturn": -0.3496,
        "beta3Year": 1.08,
        "totalAssets": 17194252,
        "yield": 0,
        "fundFamily": "Virtus",
        "fundInceptionDate": 1418688000,
        "legalType": "Exchange Traded Fund",
        "threeYearAverageReturn": -0.0113,
        "fiveYearAverageReturn": -0.0138,
        "lastSplitFactor": null
    },
    "summaryProfile": {
        "phone": "NA",
        "longBusinessSummary": "Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (\"lead drug\") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.",
        "companyOfficers": [],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": 0.0133006405,
        "regularMarketChange": 0.32559967,
        "regularMarketTime": "2023-01-06T17:17:06.000Z",
        "priceHint": 2,
        "regularMarketPrice": 24.8056,
        "regularMarketDayHigh": 25.07,
        "regularMarketDayLow": 24.59,
        "regularMarketVolume": 1590,
        "averageDailyVolume10Day": 2980,
        "averageDailyVolume3Month": 2983,
        "regularMarketPreviousClose": 24.48,
        "regularMarketSource": "DELAYED",
        "regularMarketOpen": 24.59,
        "exchange": "PCX",
        "exchangeName": "NYSEArca",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "ETF",
        "symbol": "BBC",
        "underlyingSymbol": null,
        "shortName": "Virtus LifeSci Biotech Clinical",
        "longName": "Virtus LifeSci Biotech Clinical Trials ETF",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null
    }
}